CompaniesIntelGenx

IntelGenx

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

52

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
Funding History (20)
8-K
Feb 28, 2025
8-K
Oct 7, 2024
8-K
Jul 23, 2024
8-K
Jun 7, 2024
8-K
May 21, 2024
8-K
May 8, 2024
8-K
Mar 25, 2024
DEF 14A
Mar 21, 2024
8-K
Feb 20, 2024
8-K
Feb 14, 2024